Israeli device spreads warmth during surgery:
This article was originally published in Clinica
Executive Summary
Israeli company MTRE Advanced Technology expects to receive US FDA approval in the first half of next year for a device that controls the temperature of patients during surgery. The microprocessor-controlled, water warmed suit prevents hypothermia during general anaesthetic, a side-effect that affects as many as 65% of patients, according to the Caesarea-based company. The Allon device has been submitted to the FDA for use in general anaesthesia surgery, intensive care units and emergency department trauma cases.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.